TrialCPT: pharmacometrics & systems pharmacology2017

Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight.

M M Hutmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.